Modeling and validating Bayesian accrual models on clinical data and simulations using adaptive priors
暂无分享,去创建一个
Byron J Gajewski | Yu Jiang | Matthew S Mayo | Steve Simon | M. Mayo | B. Gajewski | Steve Simon | Yu Jiang
[1] Byron J Gajewski,et al. Predicting accrual in clinical trials with Bayesian posterior predictive distributions , 2008, Statistics in medicine.
[2] R. Gray,et al. Preliminary evaluation of factors associated with premature trial closure and feasibility of accrual benchmarks in phase III oncology trials , 2010, Clinical trials.
[3] Determinants of patient recruitment in a multicenter clinical trials group: trends, seasonality and the effect of large studies , 2001, BMC medical research methodology.
[4] Steve,et al. Bmc Medical Research Methodology Open Access Applications of Bayesian Approach in Modelling Risk of Malaria-related Hospital Mortality , 2003 .
[5] K. Pile,et al. The prevalence of underpowered randomized clinical trials in rheumatology. , 2005, The Journal of rheumatology.
[6] H. C. Williams,et al. Inadequate size of ‘negative’ clinical trials in dermatology , 1993, The British journal of dermatology.
[7] J. Ibrahim,et al. Power prior distributions for regression models , 2000 .
[8] Vladimir V Anisimov,et al. Modelling, prediction and adaptive adjustment of recruitment in multicentre trials , 2007, Statistics in medicine.
[9] Byron J Gajewski,et al. On the Existence of Constant Accrual Rates in Clinical Trials and Direction for Future Research. , 2012, International journal of statistics and probability.
[10] Vegar Rangul,et al. Reliability and validity of the international physical activity questionnaire in the Nord-Trøndelag health study (HUNT) population of men , 2008, BMC medical research methodology.
[11] Qi Long,et al. Joint monitoring and prediction of accrual and event times in clinical trials , 2012, Biometrical journal. Biometrische Zeitschrift.
[12] T. Philipson,et al. Pharmacy cost sharing, antiplatelet therapy utilization, and health outcomes for patients with acute coronary syndrome. , 2010, The American journal of managed care.
[13] Keying Ye,et al. Evaluating water quality using power priors to incorporate historical information , 2006 .
[14] Andrew Cook,et al. A systematic review of models to predict recruitment to multicentre clinical trials , 2010, BMC medical research methodology.
[15] Arianne P Verhagen,et al. Survey among 78 studies showed that Lasagna's law holds in Dutch primary care research. , 2007, Journal of clinical epidemiology.
[16] Bradley P Carlin,et al. Hierarchical Commensurate and Power Prior Models for Adaptive Incorporation of Historical Information in Clinical Trials , 2011, Biometrics.
[17] J. Casanovas,et al. Clinical trial optimization: Monte Carlo simulation Markov model for planning clinical trials recruitment. , 2007, Contemporary clinical trials.
[18] D. Saxena,et al. Negative studies published in Indian medical journals are underpowered. , 2011, Indian pediatrics.
[19] Michael Branson,et al. A note on the power prior , 2009, Statistics in medicine.
[20] Qi Long,et al. Modeling and prediction of subject accrual and event times in clinical trials: a systematic review , 2012, Clinical trials.
[21] R. Breau,et al. Inadequate statistical power of negative clinical trials in urological literature. , 2006, The Journal of urology.
[22] H. Massett,et al. Power of an effective clinical conversation: improving accrual onto clinical trials. , 2012, Journal of oncology practice.
[23] Rickey Edward Carter,et al. Application of stochastic processes to participant recruitment in clinical trials. , 2004, Controlled clinical trials.
[24] S. Senn,et al. Some issues in predicting patient recruitment in multi‐centre clinical trials , 2013, Statistics in medicine.